SCHEMBL5690979

SCHEMBL5690979

Cc1ccc(S(=O)(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2cccc(NC(=O)C3CCN(C(=O)OC(C)(C)C)CC3)c2)C(=O)O)cc1

nearest known ligand 0.57

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.53
ITGB1 P05556 5/20 0.50
HCRTR1 O43613 4/20 0.50
HCRTR2 O43614 4/20 0.50
ITGA5 P08648 3/20 0.50
ITGA4 P13612 3/20 0.50
ITGA2 P17301 1/20 0.47
MAPK1 P28482 2/20 0.47
ITGAV P06756 1/20 0.46
POLB P06746 1/20 0.46
MAPT P10636 1/20 0.46
YAP1 P46937 1/20 0.46
FKBP1A P62942 1/20 0.45
TSHR P16473 1/20 0.44
CCKBR P32239 1/20 0.44
KDM4E B2RXH2 1/20 0.44
TP53 P04637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5690682 0.94 HCRTR1 (0.51) ALDH1A1HCRTR1HCRTR2ITGA4MAPK1
SCHEMBL5690885 0.91 ITGB1 (0.58) ALDH1A1ITGB1ITGA5ITGA4MAPK1
SCHEMBL5692071 0.91 HCRTR1 (0.53) ALDH1A1ITGB1HCRTR1HCRTR2ITGA5
SCHEMBL5690244 0.88 ALDH1A1 (0.56) ALDH1A1ITGB1HCRTR1HCRTR2ITGA5
SCHEMBL5690719 0.86 ITGB1 (0.57) ALDH1A1ITGB1ITGA5ITGA4MAPK1
SCHEMBL5690486 0.84 HCRTR1 (0.54) ALDH1A1HCRTR1HCRTR2MAPK1POLB
SCHEMBL5690873 0.84 ITGB1 (0.60) ALDH1A1ITGB1ITGA5ITGA4ITGA2
SCHEMBL5691183 0.84 ITGB1 (0.60) ALDH1A1ITGB1ITGA5ITGA4ITGA2
SCHEMBL5691000 0.82 ITGB1 (0.59) ALDH1A1ITGB1ITGA5ITGA4MAPK1
SCHEMBL5690998 0.82 ITGB1 (0.59) ALDH1A1ITGB1ITGA5ITGA4MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1001974-B1 4-AMINO-PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 ELAN PHARM INC (US) 2006-05-24 EP claimed
US-6291453-B1 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4 ATHENA NEUROSCIENCES, INC. 2001-09-18 US claimed
EP-1001974-A1 4-AMINO-PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 Elan Pharmaceuticals, Inc. (US) 2000-05-24 EP claimed
WO-1999006434-A1 4-AMINO-PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 ELAN PHARMACEUTICALS INC. (US) 1999-02-11 WO claimed
EP-1001974-B1 4-AMINO-PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 ELAN PHARM INC (US) 2006-05-24 EP disclosed
US-6291453-B1 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4 ATHENA NEUROSCIENCES, INC. 2001-09-18 US disclosed
EP-1001974-A1 4-AMINO-PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 Elan Pharmaceuticals, Inc. (US) 2000-05-24 EP disclosed
WO-1999006434-A1 4-AMINO-PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 ELAN PHARMACEUTICALS INC. (US) 1999-02-11 WO disclosed